Previous 10 | Next 10 |
2023-06-12 07:33:00 ET Illumina ( NASDAQ: ILMN ) added ~3% pre-market Monday as Carl Icahn, who spearheaded a proxy attack against the gene sequencing company, welcomed its leadership change following the resignation of CEO Francis deSouza. The board of directors accepted th...
2023-06-11 14:14:35 ET Illumina Inc ( NASDAQ: ILMN ), on Sunday, said its board has accepted resignation from CEO Francis deSouza who’s been leading the gene sequencing company since 2016. Charles Dadswell named interim CEO The biotech giant has already started lookin...
2023-06-11 08:09:27 ET Chief Executive of gene sequencing company Illumina ( NASDAQ: ILMN ) Francis deSouza, who narrowly survived an activist campaign led by billionaire investor Carl Icahn, has resigned, Endpoints News reported Sunday, citing the company. However, deSouz...
Illumina announces CEO transition plan PR Newswire SAN DIEGO , June 11, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of ...
2023-06-08 13:49:06 ET House Republicans are renewing a call for the Federal Trade Commission to provide it information over its review of Illumina's planned $7.1 billion takeover of cancer screening test maker GRAIL, which the regulator blocked. "The FTC's approach to the Illumina-GRAI...
Illumina releases 2022 Corporate Social Responsibility Report PR Newswire SAN DIEGO , June 5, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Respon...
2023-06-05 04:09:51 ET Summary Carl Icahn's 13F portfolio value increased from $21.75B to $22.03B, with the number of holdings rising from 16 to 17. The largest five positions account for around 90% of the entire holdings: Icahn Enterprises, CVR Energy, FirstEnergy, Occidental Pet...
2023-06-02 15:38:07 ET Over 400 patients who opted for early cancer detection tests developed by Illumina ( NASDAQ: ILMN ) subsidiary Grail received erroneous letters last month indicating that they may have developed cancer, The Financial Times reported Friday, citing an inte...
2023-06-02 12:59:36 ET Summary The BLS reported strong job growth in the service super sector, government, and healthcare. Readers may invest in sectors that add jobs. Stock ideas in healthcare, defense and aerospace, and retail discussed. Markets initially responded...
2023-06-02 10:32:37 ET Illumina's ( NASDAQ: ILMN ) board of directors has elected Hologic ( NASDAQ: HOLX ) CEO Stephen MacMillan as its new non-executive chair and Edwards Lifesciences ( NYSE: EW ) CFO Scott Ullem as an independent director following a proxy battle w...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...